Condition (MeSH)
Persistent Infection
ClinicalTrials.gov lists 36 trials for Persistent Infection or a narrower condition beneath it. New Discovery LLC has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
36 of the 36 trials are tagged with Persistent Infection itself; the rest are tagged with a narrower condition beneath it.
When did Persistent Infection trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 2 |
| 2021 | 6 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 4 |
| 2017 | 4 |
| 2016 | 2 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Persistent Infection trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 1/2 | 1 |
| Phase 2 | 1 |
| Phase 3 | 3 |
| Phase 4 | 4 |
| Not applicable | 12 |
| Observational | 13 |
How many Persistent Infection trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 3 |
| Completed | 21 |
| Unknown status | 9 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Persistent Infection trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| New Discovery LLC | 2 |
| Clarametyx Biosciences, Inc. | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Pichia pastoris) | 4 |
| CMTX-101 | 1 |
| HPV-16/18 vaccine | 1 |
| Fluorothyazinone 3900 mg | 1 |
| chitosan-coated silver nanoparticles | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Persistent Infection? (17)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies. | Cancer discovery | 2022 | Yes |
| Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis. | The Journal of infectious diseases | 2021 | Yes |
| Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (<i>The PHAGEFORCE Study Protocol</i>). | Viruses | 2021 | Yes |
| Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis. | Journal of hepatology | 2024 | No |
| Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial. | Scientific reports | 2024 | No |
Showing 5 of 17 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.